US · Healthcare

BioAge Labs, Inc (BIOA)

Drug Manufacturers - Specialty & Generic

BioAge Labs, Inc (BIOA) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BIOA

P/E ratio

18.00

BioAge Labs, Inc (BIOA) — FAQ

What is BIOA's P/E ratio?

The price-to-earnings (P/E) ratio for BioAge Labs, Inc (BIOA) is 18.00 (data as of 2026-03-23).

Does BioAge Labs, Inc pay a dividend?

Dividend yield is not available in the current snapshot for BioAge Labs, Inc (BIOA). Check the MyAverix Finance app for the latest dividend data.

What sector is BioAge Labs, Inc in?

BioAge Labs, Inc (BIOA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is BIOA listed on?

BIOA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)